We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Devon Energy
DVN
$52.2B
| $5.54M | 0.02% |
114,578
| – | – |
|
202
Deere & Co
DE
$165B
| $5.52M | 0.02% |
13,620
-447
| -3% | -$171K |
|
203
Zoetis
ZTS
$31.3B
| $5.51M | 0.02% |
32,009
+2,405
| +8% | +$416K |
|
|
DEN
204
DELISTED
Denbury Inc.
DEN
| $5.51M | 0.02% |
63,825
-10,025
| -14% | -$908K |
|
205
Northern Trust
NTRS
$21.9B
| $5.5M | 0.02% |
74,247
-1,000
| -1% | -$76.8K |
|
|
PR
206
Permian Resources
PR
$17.9B
| $5.44M | 0.02% |
496,010
-117,865
| -19% | -$1.21M |
|
207
NiSource
NI
$22.4B
| $5.34M | 0.02% |
195,147
-43,060
| -18% | -$1.2M |
|
208
MainStreet Bancshares
MNSB
$164M
| $5.33M | 0.02% |
235,363
-900
| -0.4% | -$19.7K |
|
209
3M
MMM
$87.5B
| $5.3M | 0.02% |
63,353
-7,393
| -10% | -$628K |
|
210
Novartis
NVS
$297B
| $5.27M | 0.02% |
52,233
-146,649
| -74% | -$14.7M |
|
211
Organon & Co
OGN
$3.56B
| $5.23M | 0.02% |
251,341
+219,021
| +678% | +$4.76M |
|
212
Verizon
VZ
$183B
| $5.2M | 0.02% |
139,788
-30,260
| -18% | -$1.12M |
|
213
Globe Life
GL
$13.3B
| $5.13M | 0.02% |
46,779
-220
| -0.5% | -$23.6K |
|
214
Restaurant Brands International
QSR
$25.1B
| $5.11M | 0.02% |
65,920
-7,827
| -11% | -$565K |
|
215
HCA Healthcare
HCA
$83.5B
| $5.11M | 0.02% |
16,831
-1,500
| -8% | -$417K |
|
216
Mastercard
MA
$469B
| $5.09M | 0.02% |
12,940
+560
| +5% | +$210K |
|
217
Idacorp
IDA
$8.28B
| $5.04M | 0.02% |
49,108
-8,641
| -15% | -$929K |
|
218
Chesapeake Utilities
CPK
$3.23B
| $4.98M | 0.02% |
41,849
-1,468
| -3% | -$186K |
|
219
Xylem
XYL
$27.8B
| $4.79M | 0.02% |
42,530
-3,058
| -7% | -$323K |
|
220
Invesco QQQ Trust
QQQ
$460B
| $4.71M | 0.02% |
12,757
-417
| -3% | -$140K |
|
221
Otter Tail
OTTR
$3.87B
| $4.68M | 0.02% |
59,298
| – | – |
|
222
Regis Corp
RGS
$68.8M
| $4.52M | 0.02% |
203,750
| – | – |
|
|
LSXMA
223
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $4.51M | 0.02% |
207,739
-17,300
| -8% | -$368K |
|
224
Onto Innovation
ONTO
$14.5B
| $4.41M | 0.02% |
37,850
-26,425
| -41% | -$2.52M |
|
225
GoDaddy
GDDY
$11.6B
| $4.36M | 0.02% |
58,025
| – | – |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.